On December 22, 2023, Global Medical issued the "Proposed Establishment of a ** with Related Parties", indicating that Global Medical plans to establish a ** with related parties named "General Technology Life and Health Industry Equity** (Yiwu)", with a total capital contribution of RMB 2 billion and an operating period of seven years.
*Aims to strategically invest in unlisted companies or high-growth listed companies in the field of life and health, including medical devices, biopharmaceuticals and pharmaceutical services. There are detailed regulations on management fees, income distribution and loss allocation. The limited partners include Global Leasing, General Technology Group, China Pharmaceutical, China State-Owned Enterprise Mixed Ownership Reform**, Yiwu Investment Company, Tongxiang Jinxin or its designated entities, and the partnerships used for co-investment. The manager is General Technology Ventures, and an investment committee is established as the final decision-making body for investment and exit decisions.
As of December 22, 2023**, the company's share price is 4HK$21 shares.
Announcement**: Disclaimer: This article is written by the robot, jointly incubated by Pencil Road and Hanxin Society, and the main data is provided by Hanguang Suwen. The content and data in this article are for reference only and do not constitute investment advice.